Works matching IS 15330028 AND DT 2013 AND VI 12 AND IP 3


Results: 10
    1

    Treatment Rationale and Study Design for a Randomized, Double-Blind, Placebo-Controlled Phase II Study Evaluating Onartuzumab (MetMAb) in Combination With Bevacizumab Plus mFOLFOX-6 in Patients With Previously Untreated Metastatic Colorectal Cancer.

    Published in:
    Clinical Colorectal Cancer, 2013, v. 12, n. 3, p. 218, doi. 10.1016/j.clcc.2013.04.001
    By:
    • Bendell, Johanna C.;
    • Ervin, Thomas J.;
    • Gallinson, David;
    • Singh, Jaswinder;
    • Wallace, James A.;
    • Saleh, Mansoor N.;
    • Vallone, Marcy;
    • Phan, See-Chun;
    • Hack, Stephen P.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10